4.1 Glycolysis & Pyruvate Dehydrogenase Complex

Overview of Glycolysis & Subcellular Localization

Glycolysis (also known as the Embden-Meyerhof-Parnas pathway) is the foundational metabolic pathway of carbohydrate catabolism. Occurring exclusively in the cytosol of all human cells, glycolysis converts one six-carbon hexose sugar, $\text{D-glucose}$, into two three-carbon molecules of pyruvate. This ten-step enzymatic sequence operates completely independently of molecular oxygen ($\text{O}_2$), making it the central pathway for both aerobic cellular respiration and anaerobic energy production.

From an evolutionary perspective, glycolysis is conserved across virtually all living organisms. In mature human erythrocytes (red blood cells), which lack mitochondria, glycolysis represents the sole pathway for cellular ATP generation. In tissues such as the brain, skeletal muscle, and renal medulla, glycolysis serves as the rapid initial stage of glucose utilization.

  Cytosol: D-Glucose (6C) + 2 NAD+ + 2 ADP + 2 Pi 
                │
                ▼ (10 Enzymatic Steps)
           2 Pyruvate (3C) + 2 NADH + 2 H+ + 2 ATP (Net)

---

The Ten Enzymatic Steps of Glycolysis

Glycolysis is functionally divided into two distinct phases:

1. Energy Investment Phase (Steps 1–5): Two molecules of ATP are consumed to phosphorylate hexose intermediates, destabilizing glucose and trapping it within the cell.
2. Energy Payoff Phase (Steps 6–10): Four molecules of ATP are produced via substrate-level phosphorylation, yielding a net gain of $2\text{ ATP}$ and $2\text{ NADH}$ per glucose molecule.

Stage 1: Energy Investment Phase (Steps 1–5)

Step 1: Phosphorylation of Glucose (Hexokinase vs. Glucokinase)

Glucose enters the cell through glucose transporter proteins (GLUTs). Once inside, Hexokinase (or Glucokinase in the liver and pancreatic $\beta$-cells) transfers a phosphate group from ATP to the $\text{C-6}$ hydroxyl group, forming Glucose-6-Phosphate (G6P):

$$\text{Glucose} + \text{ATP} \xrightarrow{\text{Mg}^{2+}} \text{Glucose-6-Phosphate} + \text{ADP} \quad (\Delta G^{\circ\prime} = -16.7\text{ kJ/mol})$$

This reaction is irreversible under physiological conditions. Phosphorylation traps G6P inside the cytosol because the charged phosphate group prevents G6P from exiting through GLUT transporters.

AAMC MCAT Trap: Pancreatic $\beta$-cells use glucokinase as a glucose sensor. Mutations that lower glucokinase affinity ($K_m$ increases) impair insulin secretion, resulting in Maturity-Onset Diabetes of the Young Type 2 (MODY2).

Step 2: Isomerization of G6P to Fructose-6-Phosphate

Phosphoglucose Isomerase (Phosphohexose Isomerase) reversibly converts aldose G6P to ketose Fructose-6-Phosphate (F6P) ($\Delta G^{\circ\prime} = +1.7\text{ kJ/mol}$). This moves the carbonyl oxygen from $\text{C-1}$ to $\text{C-2}$, exposing the $\text{C-1}$ primary alcohol for subsequent phosphorylation.

Step 3: Phosphorylation of F6P (The Rate-Limiting Step)

Phosphofructokinase-1 (PFK-1) transfers a phosphate group from ATP to F6P, producing Fructose-1,6-Bisphosphate (F1,6BP):

$$\text{Fructose-6-Phosphate} + \text{ATP} \xrightarrow{\text{PFK-1, Mg}^{2+}} \text{Fructose-1,6-Bisphosphate} + \text{ADP} \quad (\Delta G^{\circ\prime} = -14.2\text{ kJ/mol})$$

PFK-1 is the primary rate-limiting enzyme and major committed step of glycolysis. It is exquisitely regulated by allosteric effectors:

• Allosteric Inhibitors: High levels of ATP (signals high energy charge) and Citrate (signals abundant TCA cycle intermediates).
• Allosteric Activators: High levels of AMP (signals energy depletion) and Fructose-2,6-bisphosphate (F2,6BP).

                         ┌─────────────┐
                         │     F6P     │
                         └──────┬──────┘
                                │  PFK-1 (Rate-Limiting)
    [+ AMP, + F2,6BP] ─────────►│◄────────── [- ATP, - Citrate]
                                ▼
                         ┌─────────────┐
                         │   F1,6BP    │
                         └─────────────┘

Regulation via F2,6BP: F2,6BP is synthesized by the bifunctional enzyme PFK-2/FBPase-2. In the fed state, insulin dephosphorylates PFK-2, activating its kinase domain $\rightarrow$ increases F2,6BP $\rightarrow$ potent activation of PFK-1 $\rightarrow$ stimulates glycolysis. In the fasted state, glucagon causes PKA phosphorylation of PFK-2, activating its phosphatase domain $\rightarrow$ destroys F2,6BP $\rightarrow$ inhibits PFK-1.

Step 4: Cleavage of F1,6BP

Fructose-Bisphosphate Aldolase cleaves the six-carbon F1,6BP into two distinct three-carbon triose phosphates: Glyceraldehyde-3-Phosphate (GAP/G3P) and Dihydroxyacetone Phosphate (DHAP) ($\Delta G^{\circ\prime} = +23.8\text{ kJ/mol}$).

Step 5: Isomerization of Triose Phosphates

Triose Phosphate Isomerase (TPI) reversibly converts DHAP into a second molecule of GAP ($\Delta G^{\circ\prime} = +7.5\text{ kJ/mol}$). At this junction, one hexose glucose molecule has yielded two identical molecules of GAP. All subsequent reactions are doubled per glucose molecule.

---

Stage 2: Energy Payoff Phase (Steps 6–10)

Step 6: Oxidation and Phosphorylation of GAP

Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) oxidizes and phosphorylates GAP to form 1,3-Bisphosphoglycerate (1,3-BPG):

$$\text{GAP} + \text{NAD}^+ + \text{P}_i \xrightarrow{\text{GAPDH}} \text{1,3-BPG} + \text{NADH} + \text{H}^+ \quad (\Delta G^{\circ\prime} = +6.3\text{ kJ/mol})$$

This is the only oxidation step in glycolysis. High-energy electrons are transferred to $\text{NAD}^+$ to form NADH. Inorganic phosphate ($\text{P}_i$) is incorporated to create a high-energy mixed anhydride acyl-phosphate bond at $\text{C-1}$. Arsenate ($\text{AsO}_4^{3-}$) competes with $\text{P}_i$ here, uncoupling glycolysis without net ATP production.

Step 7: First Substrate-Level Phosphorylation

Phosphoglycerate Kinase (PGK) transfers the high-energy $\text{C-1}$ phosphate from 1,3-BPG to ADP, forming 3-Phosphoglycerate (3-PG) and ATP:

$$\text{1,3-BPG} + \text{ADP} \xrightarrow{\text{PGK, Mg}^{2+}} \text{3-PG} + \text{ATP} \quad (\Delta G^{\circ\prime} = -18.5\text{ kJ/mol})$$

Because this step occurs twice per glucose, it produces $2\text{ ATP}$, restoring the two ATP molecules invested in Stage 1.

Step 8: Isomerization of 3-PG to 2-PG

Phosphoglycerate Mutase shifts the phosphate ester from $\text{C-3}$ to $\text{C-2}$, forming 2-Phosphoglycerate (2-PG) ($\Delta G^{\circ\prime} = +4.4\text{ kJ/mol}$) via a 2,3-bisphosphoglycerate intermediate.

Step 9: Dehydration of 2-PG to Phosphoenolpyruvate

Enolase removes a molecule of water from 2-PG, introducing a double bond to create Phosphoenolpyruvate (PEP) ($\Delta G^{\circ\prime} = +7.5\text{ kJ/mol}$):

$$\text{2-PG} \xrightarrow{\text{Enolase}} \text{PEP} + \text{H}_2\text{O}$$

This dehydration rearranges energy within the molecule, creating an enol phosphate bond with extremely high phosphate group transfer potential ($\Delta G^{\circ\prime} = -61.9\text{ kJ/mol}$). Enolase is inhibited by fluoride ions ($\text{F}^-$).

Step 10: Second Substrate-Level Phosphorylation

Pyruvate Kinase (PK) transfers the high-energy phosphate from PEP to ADP, generating Pyruvate and ATP:

$$\text{PEP} + \text{ADP} + \text{H}^+ \xrightarrow{\text{Pyruvate Kinase, Mg}^{2+}, \text{K}^+} \text{Pyruvate} + \text{ATP} \quad (\Delta G^{\circ\prime} = -31.4\text{ kJ/mol})$$

This reaction is irreversible. Pyruvate kinase is allosterically activated by Fructose-1,6-bisphosphate (feed-forward activation) and inhibited by ATP, Acetyl-CoA, and alanine. In the liver, glucagon leads to PKA-mediated phosphorylation, inactivating pyruvate kinase to prevent glucose breakdown during fasting.

---

Summary Table: The 10 Steps of Glycolysis

---

Thermodynamics, Energy Yield & Phosphorylation Mechanisms

The overall net chemical equation for glycolysis is:

$$\text{Glucose} + 2\text{ NAD}^+ + 2\text{ ADP} + 2\text{ P}_i \rightarrow 2\text{ Pyruvate} + 2\text{ NADH} + 2\text{ H}^+ + 2\text{ ATP} + 2\text{ H}_2\text{O}$$ $$\Delta G^{\circ\prime}_{\text{overall}} \approx -85\text{ kJ/mol}$$

Substrate-Level vs. Oxidative Phosphorylation

• Substrate-Level Phosphorylation: Direct enzymatic transfer of a high-energy phosphate group from a phosphorylated metabolic intermediate (e.g., 1,3-BPG or PEP) to ADP to form ATP, independent of molecular oxygen or a proton gradient. Glycolysis produces $4\text{ ATP}$ total ($2\text{ net}$) solely via substrate-level phosphorylation.
• Oxidative Phosphorylation: Synthesis of ATP driven by the electrochemical proton gradient across the inner mitochondrial membrane, coupled to electron transport through the respiratory chain.

---

Anaerobic Fermentation & Lactate Dehydrogenase

Under aerobic conditions, pyruvate enters the mitochondria and the $2\text{ NADH}$ generated by GAPDH donate their electrons to the electron transport chain (via mitochondrial shuttles). However, under anaerobic conditions (hypoxia in exercising skeletal muscle) or in cells lacking mitochondria (erythrocytes), the electron transport chain cannot reoxidize NADH.

Without a mechanism to recycle NADH, cytosolic $\text{NAD}^+$ would become rapidly depleted, halting GAPDH (Step 6) and completely stopping glycolysis. To prevent this, cells utilize Lactate Dehydrogenase (LDH):

$$\text{Pyruvate} + \text{NADH} + \text{H}^+ \xrightleftharpoons{\text{LDH}} \text{Lactate} + \text{NAD}^+ \quad (\Delta G^{\circ\prime} = -25.1\text{ kJ/mol})$$

               Glycolysis (Step 6): GAP ──────► 1,3-BPG
                                     ▲             │
                              NAD+   │             │ NADH + H+
                                     │             ▼
             Lactic Fermentation: Lactate ◄──── Pyruvate

LDH reduces pyruvate to lactate while reoxidizing $\text{NADH}$ to $\text{NAD}^+$. The regenerated $\text{NAD}^+$ feeds back into Step 6, allowing glycolysis to continue producing $2\text{ ATP}$ per glucose anaerobically. Lactate is released into the blood and carried to the liver, where it is converted back to glucose via gluconeogenesis (The Cori Cycle).

---

The Pyruvate Dehydrogenase (PDH) Complex

Under aerobic conditions, pyruvate produced in the cytosol crosses the outer mitochondrial membrane via porins and enters the mitochondrial matrix through the pyruvate translocase proton symporter. In the matrix, pyruvate undergoes oxidative decarboxylation to form Acetyl-CoA.

$$\text{Pyruvate} + \text{CoA-SH} + \text{NAD}^+ \xrightarrow{\text{PDH Complex}} \text{Acetyl-CoA} + \text{CO}_2 + \text{NADH} + \text{H}^+ \quad (\Delta G^{\circ\prime} = -33.4\text{ kJ/mol})$$

This exergonic reaction irreversibly links glycolysis to the Citric Acid Cycle.

Structural Organization & Multienzyme Catalytic Components

The PDH complex is a massive multienzyme cluster composed of three distinct enzymes:

1. $E_1$: Pyruvate Dehydrogenase (Decarboxylase Component): Decarboxylates pyruvate, releasing $\text{CO}_2$, and attaches the remaining hydroxyethyl group to thiamine pyrophosphate.
2. $E_2$: Dihydrolipoyl Transacetylase: Transfers the acetyl group from lipoamide to Coenzyme A, producing Acetyl-CoA and reducing lipoamide.
3. $E_3$: Dihydrolipoyl Dehydrogenase: Reoxidizes dihydrolipoamide back to lipoamide using bound $\text{FAD}$, then transfers electrons to $\text{NAD}^+$, yielding $\text{NADH} + \text{H}^+$.

The Five Essential Cofactors

Successful PDH complex activity requires five cofactors, derived from four B-complex vitamins plus lipoic acid. A classic MCAT mnemonic is "Tender Loving Care For Nancy":

1. TPP (Thiamine Pyrophosphate): Derived from Vitamin $\text{B}_1$ (Thiamine); bound to $E_1$.
2. Lipoic Acid / Lipoamide: Covalently attached to a lysine residue of $E_2$; acts as a flexible swinging arm.
3. CoA (Coenzyme A / CoA-SH): Derived from Vitamin $\text{B}_5$ (Pantothenic acid); substrate for $E_2$.
4. FAD (Flavin Adenine Dinucleotide): Derived from Vitamin $\text{B}_2$ (Riboflavin); prosthetic group on $E_3$.
5. $\text{NAD}^+$ (Nicotinamide Adenine Dinucleotide): Derived from Vitamin $\text{B}_3$ (Niacin); terminal electron acceptor for $E_3$.

Regulation of the Pyruvate Dehydrogenase Complex

The PDH complex is regulated by both end-product inhibition and covalent modification:

• End-Product Inhibition: High concentrations of Acetyl-CoA inhibit $E_2$, while high concentrations of NADH inhibit $E_3$.
• Covalent Modification:
  • PDH Kinase: Phosphorylates $E_1$ on a specific serine residue, inactivating the complex. PDH kinase is activated by high energy charge indicators: [ATP], [NADH], and [Acetyl-CoA]. It is inhibited by [ADP], [$\text{NAD}^+$], [CoA-SH], and [Pyruvate].
  • PDH Phosphatase: Dephosphorylates $E_1$, activating the complex. PDH phosphatase is activated by $\text{Ca}^{2+}$ (signaling muscle contraction) and insulin (signaling fed state in liver).

---

Clinical Correlations & AAMC MCAT Traps

• Thiamine Deficiency (Beriberi & Wernicke-Korsakoff Syndrome): Inadequate Vitamin $\text{B}_1$ depletes TPP, severely impairing $E_1$ of PDH and $\alpha$-ketoglutarate dehydrogenase. Tissues dependent on aerobic respiration (brain, heart) suffer severe ATP depletion, leading to lactic acidosis, confusion, ataxia, and heart failure.
• Arsenic Poisoning: Arsenite ($\text{AsO}_3^{3-}$) forms a stable covalent complex with the sulfhydryl groups of lipoic acid ($E_2$), stopping PDH and TCA cycle function.
• Lactic Acidosis: Inherited deficiencies in PDH subunit genes or severe tissue hypoxia cause pyruvate accumulation, driving excessive LDH conversion to lactate, resulting in metabolic acidosis.